source
- HHS launches funding programs to accelerate U.S. clinical trials amid rising Chinese competitionHHS announced new initiatives aimed at speeding up clinical trial development in the United States. The department introduced a five-year program called "Surpass" that seeks proposals from teams wi…
- Eli Lilly ends partnership with Foghorn Therapeutics, prompting 40% staff cut at biotechEli Lilly announced it is withdrawing from its collaboration with Foghorn Therapeutics on a synthetic lethality drug program. Following the pullback, Foghorn said it will cut roughly 40% of its wo…